Molina Healthcare price target lowered to $380 from $400 at Truist
The Fly

Molina Healthcare price target lowered to $380 from $400 at Truist

Truist analyst David MacDonald lowered the firm’s price target on Molina Healthcare to $380 from $400 but keeps a Buy rating on the shares after its Q4 results. The company has had a solid finish to 2022 marked by membership, revenue, MCR and adjusted EPS all better than the firm’s expectations, though its price target cut reflects more recent market multiples, the analyst tells investors in a research note.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on MOH:

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App